SCHEMBL5049451

SCHEMBL5049451

CCCCOc1ccc(-c2cn(CC)nn2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 7/20 0.54
CYP2D6 P10635 8/20 0.51
CYP2C9 P11712 6/20 0.51
CYP2C19 P33261 6/20 0.51
CYP1A2 P05177 5/20 0.51
CYP3A4 P08684 3/20 0.49
NPC1 O15118 5/20 0.48
RAB9A P51151 5/20 0.48
ATM Q13315 1/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
KDM4E B2RXH2 2/20 0.48
ALDH1A1 P00352 2/20 0.48
MAPT P10636 2/20 0.48
LMNA P02545 1/20 0.48
TSHR P16473 1/20 0.48
HSD17B10 Q99714 1/20 0.48
L3MBTL1 Q9Y468 3/20 0.47
HPGD P15428 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5053642 0.96 CYP19A1 (0.50) CYP19A1CYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL18925015 0.84 MEN1 (0.64) NPC1RAB9AMEN1KMT2A
SCHEMBL16263167 0.84 CYP2D6 (0.47) CYP19A1CYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL28525427 0.81 CYP19A1 (0.60) CYP19A1NPC1RAB9AATMMEN1
SCHEMBL5049564 0.80 MEN1 (0.49) CYP1A2NPC1RAB9AMEN1KMT2A
SCHEMBL29966023 0.80 MEN1 (0.49) CYP19A1NPC1RAB9AMEN1KMT2A
SCHEMBL16264735 0.79 MEN1 (0.50) CYP19A1NPC1RAB9AMEN1KMT2A
SCHEMBL5051923 0.78 HDAC3 (0.64) NPC1RAB9AMEN1KMT2AL3MBTL1
SCHEMBL28561223 0.77 MEN1 (0.44) CYP19A1NPC1RAB9AMEN1KMT2A
SCHEMBL9137418 0.77 SRC (0.60) CYP19A1NPC1RAB9AATMMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1921072-A1 1,2,3-Triazole derivatives as cannabinoid-receptor modulators Laboratorios del Dr. Esteve S.A. (ES) 2008-05-14 EP claimed
EP-1921072-A1 1,2,3-Triazole derivatives as cannabinoid-receptor modulators Laboratorios del Dr. Esteve S.A. (ES) 2008-05-14 EP disclosed